Tranexamic Acid

Overview

Tranexamic Acid is antifibrinolytic agent. Tranexamic Acid is analogue of aminocaproic acid. Chemically Tranexamic Acid is identified as trans-4-(aminomethyl) cyclohexanecarboxylic acid. Tranexamic Acid is effective to reversed the effects of streptokinase or other fibrinolytic activity. It may be used for conditions in which bleeding control is required such as after surgery or injury, recurrent nosebleeds or abnormal vaginal bleeding.

Categories

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Tranexamic Acid is known to interact with other drugs, the details of drug interactions is as follows:

Severity N/A

Factor VIII

Interaction of Factor VIII with Tranexamic Acid

These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Back to top

Side Effects

Back to top

Dosage

Tranexamic Acid's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage
250 to 750 mg500 (500)8 hourlyPO
0.5 to 1 g0.75 (0.75)8 hourlySlow IVLocal fibrinolysis

Paedriatic Dosage (20kg)
25 mg/kg25 (25)8 hourlyOral-

Neonatal Dosage (3kg)
25 mg/kg25 (25)8 hourlyOral-

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Tranexamic Acid

Back to top

Previous Drug Generic - Next Drug Generic


Suggested Pages